MTOR and Alzheimer disease: The first time p53 activity was found to be altered in AD was in skin fibroblasts from sporadic Alzheimer’s disease patients.[89] Since then, numerous studies have shown that p53 dysregulation induces or exacerbates AD.[90,91] The mTOR signaling pathway has been implicated in p53 activity in several studies.